ADVANCES in therapy always constitute a good reason for presenting a familiar subject. Indeed, the chronology of juvenile nasopharyngeal hemangiofibroma reflects this steplike progress in the almost cyclical reappearance of reports in the otolaryngological literature as improvements in handling this sometimes alarming condition manifest themselves.
In reviewing the literature, I received the impression that a greater number of these cases were reported in the foreign journals, European and South American, than in those of this country. Part of this may be due to the depressant effect of the last war on medical literature in general, especially as regards the number of reports from this country compared with that of South America.
It has been the privilege of very few men to see several of these interesting cases, most reports being limited to one, two, three, four or six. In fact, when larger numbers of cases are reported often cases are
KERWIN RW. JUVENILE NASOPHARYNGEAL ANGIOFIBROMA. AMA Arch Otolaryngol. 1951;53(4):397–405. doi:10.1001/archotol.1951.03750040046005
Customize your JAMA Network experience by selecting one or more topics from the list below.